Tirzepatide death link?

Exactly! I didn't even realize it wasn't just a willpower thing until I started a GLP-1, and poof, the constant hunger and food thoughts were gone. Easy to blame people when you haven't felt it yourself.
 
She probably saw a doctor before starting and had bloodwork. Most likely, her kidneys failed because of dehydration and sepsis from pancreatitis... Possibly a quick pancreatitis from a gallstone because of obesity. Maybe she was already losing some weight before the meds?
 
I work with a lot of nurses (in the US, but I bet the UK is the same). She was probably super dehydrated. Nurses who work too much don't stop to drink water to avoid bathroom breaks. It's almost a competition for some. Standard 12-13 hour shifts, home to sleep, then back to work three days in a row, or more if they want overtime? Kidney problems. Then, pancreatitis on top of that, which dehydrates you more? Perfect storm.

I'm not saying it wasn't the GLP-1, but there were probably other things going on too.
 
As a nurse and nurse practitioner, I agree about the "nurse's bladder." I can go a whole day without a bathroom break. But that wouldn't CAUSE pancreatitis... A gallstone is most likely in someone overweight. But pancreatitis causes a lot of nausea and throwing up, which, if you're already dehydrated, is super hard on your kidneys. When you get sepsis, clots form and hurt the kidneys. If she had a gallbladder, gallstones are likely...... "Female, fat, fertile, and in their 40s" is how we remember the typical gallbladder patient.
 
I'm seeing people online talk a lot about fatigue with these meds. One person said they're "drained 24/7 and can barely do anything besides lay down and scroll on my phone."
 
Man, I hope I don't get that fatigue thing @dose-day-dread is talking about! I'm just starting, so I'm worried about side effects. Saw a thread where one person said "My first two weeks were so horrible with side effects like yours that I almost quit. Then the third week everything evened out."
 
You can find the full study details here - Jastreboff et al. released this in 2025 through the New England Journal of Medicine, volume 392 issue 10, pages 958 onwards. It covers tirzepatide's effects on obesity and diabetes prevention.
 
sry's us warehouse was solid sometimes before things got messy with particles and they disappeared. lately i prefer buying from small domestic resellers on tg. my favorite us warehouse has high minimums now and doesn't have much variety for this stuff except overpriced options.
 
Death-linked framing usually involves confounding factors that don't make the headline - pre-existing conditions, other drugs, or misattribution. The full article context matters before drawing conclusions.
 
You must log in or register to reply here.
Back
Top